Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Italy.
Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Italy.
Heart Fail Clin. 2022 Jan;18(1):101-113. doi: 10.1016/j.hfc.2021.07.011. Epub 2021 Oct 22.
In the wide phenotypic spectrum of cardiomyopathies, sudden cardiac death (SCD) has always been the most visible and devastating disease complication. The introduction of implantable cardioverter-defibrillators for SCD prevention by the late 1980s has moved the question from how to whom we should protect from SCD, leaving clinicians with a measure of uncertainty regarding the most reliable option to guide identification of the highest-risk patients. In this review, we will go through all the available evidence in the field of arrhythmic expression and arrhythmic risk stratification in the different phenotypes of cardiomyopathies to provide practical suggestions in daily clinical management.
在心肌病的广泛表型谱中,心脏性猝死(SCD)一直是最明显和最具破坏性的疾病并发症。植入式心脏复律除颤器(ICD)于 20 世纪 80 年代末问世,用于预防 SCD,这使得问题从我们应该保护谁免受 SCD 转变为如何保护,这让临床医生在确定最可靠的选择以指导识别最高风险患者时存在一定程度的不确定性。在这篇综述中,我们将回顾心肌病不同表型中心律失常表现和心律失常风险分层的所有现有证据,为日常临床管理提供实用建议。